Esthesioneuroblastoma (olfactory neuroblastoma) with ectopic ACTH syndrome: A multidisciplinary case presentation from the Joan Karnell Cancer Center of Pennsylvania Hospital

Oncologist

Volumn 15, Issue 1, 2010, Pages 51-58

  Mintzer, David M ^a   Zheng, Sarah ^a   Nagamine, Michiko ^a   Newman, Jason ^a   Benito, Maria ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Ectopic ACTH; Esthesioneuroblastoma; Paraneoplastic disease; Skull based tumors

Indexed keywords

BICARBONATE; CARBOPLATIN; CORTICOTROPIN; ETOPOSIDE; GLUCOSE; HYDROCORTISONE; KETOCONAZOLE; OCTREOTIDE; POTASSIUM; TEMOZOLOMIDE;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CANCER RECURRENCE; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL FEATURE; CONFUSION; CORTICOTROPIN BLOOD LEVEL; CRANIOFACIAL SURGERY; CRANIOTOMY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISTANT METASTASIS; DRUG WITHDRAWAL; DYSPHASIA; ECTOPIC CORTICOTROPIN PRODUCTION; EPISTAXIS; ESTHESIONEUROBLASTOMA; FATIGUE; FOCAL EPILEPSY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERTENSION; HYPONATREMIA; HYPOTHYROIDISM; INTRACRANIAL TUMOR; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MANDIBLE; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; NASOPHARYNX; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PH; PNEUMOCOCCAL MENINGITIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RELAPSE; TREATMENT RESPONSE;

ACTH SYNDROME, ECTOPIC; ADRENOCORTICOTROPIC HORMONE; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; DACARBAZINE; ESTHESIONEUROBLASTOMA, OLFACTORY; HUMANS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; KETOCONAZOLE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASAL CAVITY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; OCTREOTIDE;

EID: 75649118231     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-0016     Document Type: Article

References (36)

1. Finkelstein SD, Hirose T, VandenBerg SR. Olfactory neuroblastoma. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics: Tumours of the Nervous System. Lyon, France: World Health Organization, IARC, 2000: 150-152.
2. Hyams V, Batsakis J, Michaels L. Atlas of tumor pathology. Armed Forces Institute of Pathology 1988;25:240-248.
3. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: A metaanalysis and review. Lancet Oncol 2001;2:683-690.
4. Carney ME, O'Reilly RC, Sholevar B et al. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma). J Neurooncol 1995;26:35-43.
5. Schwab M, Shimada H, Joshi V et al. Neuroblastic tumours of adrenal gland and sympathetic nervous system. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System, Lyon, France: World Health Organization, IARC, 2000:153.
6. Sorensen PH, Wu JK, Berean KW et al. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci U S A 1996;93:1038-1043.
7. Sciñska A, Korkosz A, Sienkiewicz-Jarosz H et al. [Olfactory neuroblastoma (esthesioneuroblastoma): Etiopathogenesis, diagnosis, and treatment.] Otolaryngol Pol 2006;60:849-858. In Polish.
8. Morita A, Ebersold MJ, Olsen KD et al. Esthesioneuroblastoma: Prognosis and management. Neurosurgery 1993;32:706-714; discussion 714-715.
9. Jethanamest D, Morris LG, Sikora AG et al. Esthesioneuroblastoma: A population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007;133:276-280.
10. McElroy EA Jr, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: The Mayo Clinic experience. Neurosurgery 1998;42: 1023-1027; discussion 1027-1028.
11. Kim DW, Jo YH, Kim JH et al. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 2004;101: 2257-2260.
12. Loy AH, Reibel JF, Read PW et al. Esthesioneuroblastoma: Continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg 2006;132:134-138.
13. Porter AB, Bernold DM, Giannini C et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol 2008;90:201-204.
14. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: A general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 1997;7:2683-2706.
15. Bachar G, Goldstein DP, Shah M et al. Esthesioneuroblastoma: The Princess Margaret Hospital experience. Head Neck 2008;30:1607-1614.
16. Dias FL, Sa GM, Lima RA et al. Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 2003;129:1186-1192.
17. Shah JP, Galicich JH. Craniofacial resection for malignant tumors of ethmoid and anterior skull base. Arch Otolaryngol 1977;103:514-517.
18. Kassam AB, Thomas A, Carrau RL et al. Endoscopic reconstruction of the cranial base using a pedicled nasoseptal flap. Neurosurgery 2008;63(suppl 1):ONS44-ONS52; discussion ONS52-ONS53.
19. Chamberlain MC. Treatment of intracranial metastatic esthesioneuroblastoma. J Clin Oncol 2002;20:357-358.
20. Kiyota N, Tahara M, Fujii S et al. Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: A retrospective analysis of 12 cases. Cancer 2008;112:885-891.
21. Wick W, Wick A, Kk̈er W et al. Intracranial metastatic esthesioneuroblastoma responsive to temozolomide. J Neurooncol 2004;70:73-75.
22. Reznik M, Melon J, Lambricht M et al. [Neuroendocrine tumor of the nasal cavity (esthesioneuroblastoma). Apropos of a case with paraneoplastic Cushing's syndrome.] Ann Pathol 1987;7:137-142. In French.
23. Fish S, Harish S, Tapino E et al. Ectopic ACTH syndrome caused by olfactory neuroblastoma. Resid Staff Physician 2005;51:30-33.
24. Yu J, Koch CA, Patsalides A et al. Ectopic Cushing's syndrome caused by an esthesioneuroblastoma. Endocr Pract 2004;10:119-124.
25. Arnesen MA, Scheithauer BW, Freeman S et al. Cushing's syndrome secondary to olfactory neuroblastoma. Ultrastruct Pathol 1994;18:61-68.
26. Kanno K, Morokuma Y, Tateno T et al. Olfactory neuroblastoma causing ectopic ACTH syndrome. Endocr J 2005;52:675-681.
27. Josephs L, Jones L, Marenette L et al. Cushing's syndrome: An unusual presentation of olfactory neuroblastoma. Skull Base 2008;18:73-76.
28. Koo BK, An JH, Jeon KH et al. Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocr J 2008;55:469-475.
29. Isidori AM, Kaltsas GA, Pozza C et al. The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management and long-term followup. J Clin Endocrinol Metab 2006;91:371-377.
30. Ilias I, Torpy DJ, Pacak K et al. Cushing's syndrome due to ectopic corticotrophin secretion: Twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005;90:4955-4962.
31. Tabarin A, Valli N, Chanson P et al. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1999;84:1193-1202.
32. von Werder K, Muller OA, Stalla GK. Somatostatin analogs in ectopic corticotropin production. Metabolism 1996;45(suppl 1):129-131.
33. Uwaifo GI, Koch CA, Hishberg B et al. Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome? J Endocrinol Invest 2003;26:710-717.
34. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: A metaanalysis and review. Lancet Oncol 2001;2:683-690.
35. Jethanamest D, Morris LG, Sikora AG et al. Esthesioneuroblastoma: A population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007;133:276-280.
36. Ilias I, Torpy DJ, Pacak K et al. Cushing's syndrome due to ectopic corticotrophin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005;90:4955-4962.